missing translation for 'onlineSavingsMsg'
Learn More
Learn More
TNF RI/TNFRSF1A Antibody, Novus Biologicals™
Rabbit Polyclonal Antibody
Brand: Novus Biologicals NBP1-97453-0.025MG
This item is not returnable.
View return policy
Description
TNF RI/TNFRSF1A Polyclonal specifically detects TNF RI/TNFRSF1A in Human, Mouse, Rat, Porcine, Bovine, Canine, Drosophila, Hamster, Monkey, Rabbit, Sheep, Xenopus, Yeast samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry-Paraffin.
Specifications
| TNF RI/TNFRSF1A | |
| Polyclonal | |
| Unconjugated | |
| PBS and 50% Glycerol with 0.09% Sodium Azide | |
| TNFRSF1A | |
| Synthetic peptide corresponding to a portion of mouse TNF Receptor I. | |
| 0.025 mg | |
| Apoptosis, Cancer, Cytokine Research, Death Receptor Signaling Pathway | |
| 7132 | |
| Store at -20C. Avoid freeze-thaw cycles. |
| Immunohistochemistry (Paraffin), Western Blot, Immunohistochemistry, Flow Cytometry, Immunoprecipitation | |
| 1.0 mg/mL | |
| Western Blot 1:1000, Flow Cytometry 1:20, Immunohistochemistry 1:10-1:500, Immunoprecipitation 12.5 ug/ml, Immunohistochemistry-Paraffin 1:10-1:500 | |
| CD120a, CD120a antigen, FPF, p55, p55-R, p60, TNFARMGC19588, TNF-R, TNF-R1, TNFR1TBP1, TNFR55, TNF-R55, TNFR60, TNF-RI, TNF-R-I, TNFR-I, tumor necrosis factor binding protein 1, Tumor necrosis factor receptor 1, tumor necrosis factor receptor 1A isoform beta, tumor necrosis factor receptor superfamily member 1A, tumor necrosis factor receptor superfamily, member 1A, tumor necrosis factor receptor type 1, Tumor necrosis factor receptor type I, tumor necrosis factor-alpha receptor | |
| Rabbit | |
| Affinity Purified | |
| RUO | |
| Primary | |
| Xenopus species, Rabbit, Pig, Human, Sheep, Bovine, Canine, Hamster, Monkey, Rat, Yeast, Drosophila, Mouse | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction